Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

518 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Molecular insights into fosfomycin resistance in Escherichia coli.
Ballestero-Téllez M, Docobo-Pérez F, Portillo-Calderón I, Rodríguez-Martínez JM, Racero L, Ramos-Guelfo MS, Blázquez J, Rodríguez-Baño J, Pascual A. Ballestero-Téllez M, et al. J Antimicrob Chemother. 2017 May 1;72(5):1303-1309. doi: 10.1093/jac/dkw573. J Antimicrob Chemother. 2017. PMID: 28093485 Free article.
Inoculum effect on the efficacies of amoxicillin-clavulanate, piperacillin-tazobactam, and imipenem against extended-spectrum β-lactamase (ESBL)-producing and non-ESBL-producing Escherichia coli in an experimental murine sepsis model.
Docobo-Pérez F, López-Cerero L, López-Rojas R, Egea P, Domínguez-Herrera J, Rodríguez-Baño J, Pascual A, Pachón J. Docobo-Pérez F, et al. Antimicrob Agents Chemother. 2013 May;57(5):2109-13. doi: 10.1128/AAC.02190-12. Epub 2013 Feb 25. Antimicrob Agents Chemother. 2013. PMID: 23439636 Free PMC article.
Impact of qnrA1, qnrB1 and qnrS1 on the efficacy of ciprofloxacin and levofloxacin in an experimental pneumonia model caused by Escherichia coli with or without the GyrA mutation Ser83Leu.
Domínguez-Herrera J, Velasco C, Docobo-Pérez F, Rodríguez-Martínez JM, López-Rojas R, Briales A, Pichardo C, Díaz-de-Alba P, Rodríguez-Baño J, Pascual A, Pachón J. Domínguez-Herrera J, et al. J Antimicrob Chemother. 2013 Jul;68(7):1609-15. doi: 10.1093/jac/dkt063. Epub 2013 Mar 14. J Antimicrob Chemother. 2013. PMID: 23493313
Pharmacodynamics of fosfomycin: insights into clinical use for antimicrobial resistance.
Docobo-Pérez F, Drusano GL, Johnson A, Goodwin J, Whalley S, Ramos-Martín V, Ballestero-Tellez M, Rodriguez-Martinez JM, Conejo MC, van Guilder M, Rodríguez-Baño J, Pascual A, Hope WW. Docobo-Pérez F, et al. Antimicrob Agents Chemother. 2015 Sep;59(9):5602-10. doi: 10.1128/AAC.00752-15. Epub 2015 Jun 29. Antimicrob Agents Chemother. 2015. PMID: 26124169 Free PMC article.
Role of inoculum and mutant frequency on fosfomycin MIC discrepancies by agar dilution and broth microdilution methods in Enterobacteriaceae.
Ballestero-Téllez M, Docobo-Pérez F, Rodríguez-Martínez JM, Conejo MC, Ramos-Guelfo MS, Blázquez J, Rodríguez-Baño J, Pascual A. Ballestero-Téllez M, et al. Clin Microbiol Infect. 2017 May;23(5):325-331. doi: 10.1016/j.cmi.2016.12.022. Epub 2017 Jan 3. Clin Microbiol Infect. 2017. PMID: 28062317 Free article.
Population pharmacokinetics and pharmacodynamics of fosfomycin in non-critically ill patients with bacteremic urinary infection caused by multidrug-resistant Escherichia coli.
Merino-Bohórquez V, Docobo-Pérez F, Sojo J, Morales I, Lupión C, Martín D, Cameán M, Hope W, Pascual Á, Rodríguez-Baño J. Merino-Bohórquez V, et al. Clin Microbiol Infect. 2018 Nov;24(11):1177-1183. doi: 10.1016/j.cmi.2018.02.005. Epub 2018 Apr 10. Clin Microbiol Infect. 2018. PMID: 29649596 Free article. Clinical Trial.
Activity of fosfomycin and amikacin against fosfomycin-heteroresistant Escherichia coli strains in a hollow-fiber infection model.
Portillo-Calderón I, Ortiz-Padilla M, de Gregorio-Iaria B, Merino-Bohorquez V, Blázquez J, Rodríguez-Baño J, Rodríguez-Martínez JM, Pascual A, Docobo-Pérez F. Portillo-Calderón I, et al. Antimicrob Agents Chemother. 2023 May 1;65(5):e02213-20. doi: 10.1128/AAC.02213-20. Epub 2021 Mar 8. Antimicrob Agents Chemother. 2023. PMID: 33685903 Free PMC article.
Comparative assessment of inoculum effects on the antimicrobial activity of amoxycillin-clavulanate and piperacillin-tazobactam with extended-spectrum beta-lactamase-producing and extended-spectrum beta-lactamase-non-producing Escherichia coli isolates.
López-Cerero L, Picón E, Morillo C, Hernández JR, Docobo F, Pachón J, Rodríguez-Baño J, Pascual A. López-Cerero L, et al. Clin Microbiol Infect. 2010 Feb;16(2):132-6. doi: 10.1111/j.1469-0691.2009.02893.x. Epub 2009 Jul 15. Clin Microbiol Infect. 2010. PMID: 19614715 Free article.
Prevalence of plasmid-mediated quinolone resistance determinants qnr and aac(6')-Ib-cr in Escherichia coli and Klebsiella pneumoniae producing extended-spectrum β-lactamases in Spain.
Briales A, Rodríguez-Martínez JM, Velasco C, de Alba PD, Rodríguez-Baño J, Martínez-Martínez L, Pascual A. Briales A, et al. Int J Antimicrob Agents. 2012 May;39(5):431-4. doi: 10.1016/j.ijantimicag.2011.12.009. Epub 2012 Feb 22. Int J Antimicrob Agents. 2012. PMID: 22365240
518 results